DaVita (NYSE:DVA) Sets New 1-Year High – Still a Buy?

DaVita Inc. (NYSE:DVA)’s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $211.95 and last traded at $208.9090, with a volume of 765773 shares changing hands. The stock had previously closed at $209.75.

Analysts Set New Price Targets

A number of brokerages have issued reports on DVA. Wall Street Zen upgraded shares of DaVita from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Barclays upped their target price on shares of DaVita from $158.00 to $194.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Zacks Research raised shares of DaVita from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 7th. UBS Group boosted their price target on shares of DaVita from $190.00 to $235.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Finally, TD Cowen increased their price objective on DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research note on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $199.17.

DaVita Stock Down 1.4%

The stock has a 50-day moving average price of $181.04 and a 200 day moving average price of $148.78. The firm has a market capitalization of $13.33 billion, a price-to-earnings ratio of 19.26, a P/E/G ratio of 0.69 and a beta of 0.91.

DaVita (NYSE:DVA) last issued its earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The firm had revenue of $3.42 billion for the quarter, compared to analysts’ expectations of $3.36 billion. During the same quarter last year, the company earned $2.00 earnings per share. The firm’s revenue was up 6.0% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities analysts forecast that DaVita Inc. will post 15.07 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Joel Ackerman sold 51,471 shares of the business’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the completion of the sale, the chief financial officer directly owned 132,434 shares of the company’s stock, valued at $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Kathleen Alyce Waters sold 15,405 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $208.40, for a total value of $3,210,402.00. Following the completion of the sale, the insider directly owned 109,194 shares of the company’s stock, valued at $22,756,029.60. The trade was a 12.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.50% of the stock is owned by company insiders.

Institutional Trading of DaVita

Hedge funds have recently added to or reduced their stakes in the stock. Kesler Norman & Wride LLC increased its holdings in shares of DaVita by 0.8% in the first quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company’s stock valued at $1,048,000 after purchasing an additional 55 shares during the period. Gen Wealth Partners Inc grew its position in DaVita by 10.0% in the 4th quarter. Gen Wealth Partners Inc now owns 880 shares of the company’s stock valued at $100,000 after buying an additional 80 shares during the last quarter. NewEdge Advisors LLC increased its stake in DaVita by 20.8% in the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after buying an additional 88 shares during the period. Orion Porfolio Solutions LLC raised its position in DaVita by 4.4% during the 4th quarter. Orion Porfolio Solutions LLC now owns 2,360 shares of the company’s stock worth $268,000 after buying an additional 99 shares during the last quarter. Finally, Root Financial Partners LLC raised its position in DaVita by 128.0% during the 1st quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock worth $29,000 after buying an additional 105 shares during the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.